FDA authorizes fruit-flavored vapes—here's how to talk to patients about it
Industry Buzz
[This] decision puts at risk the progress our nation has made in reducing youth e-cigarette use. It conflicts with overwhelming scientific evidence and the FDA’s own repeated conclusions that flavors pose a substantial risk to young people.
—Yolonda C. Richardson, President and CEO of the Campaign for Tobacco-Free Kids
For the first time, the FDA has authorized fruit-flavored e-cigarettes for adult use, a decision that gives physicians a new talking point in an already complicated exam-room conversation about vaping, nicotine dependence, harm reduction, and adolescent risk.
Related: How docs are responding to the MAHA-linked trend pushing nicotine as an anti-dementia ‘hack’The agency announced May 5 that it had authorized four electronic nicotine delivery system products from Los Angeles–based Glas through the premarket tobacco product application pathway: Gold, a mango-flavored pod; Sapphire, a blueberry-flavored pod; and two menthol products, Classic Menthol and Fresh Menthol. []
The products are authorized for adults aged 21 and older, and the FDA says they include “device access restriction” technology intended to limit youth use. []
A first for fruit flavors
Until now, the FDA had authorized only tobacco- and menthol-flavored e-cigarette products. This decision marks the agency’s first authorization of fruit-flavored e-cigarettes, a category regulators have long viewed as particularly concerning because of its appeal to adolescents. []
The FDA says its review found that the benefits for adults who smoke may outweigh the risks, given the access-control features and marketing restrictions attached to the authorization. []
The Glas system requires users to verify age and identity with government-issued identification and pair the device with a smartphone via Bluetooth before use, according to the agency. []
The agency also emphasized that authorization is not the same as saying the products are safe. FDA’s own public guidance states that people who do not use tobacco products should not start, and that authorized e-cigarettes are not FDA-approved smoking cessation devices. []
Related: 4 risky 'cures' making a comeback under MAHAWhy the decision is controversial
The authorization lands after years of FDA resistance to fruit-, candy-, and dessert-flavored vaping products. Under prior regulatory actions, the agency denied more than 1 million marketing applications for flavored e-cigarette products, citing concerns about youth uptake. []
Public health groups quickly criticized the Glas decision. the Campaign for Tobacco-Free Kids called it a “big step backward,” arguing that fruit flavors remain strongly associated with adolescent appeal and warning that mango was among the flavors linked to the earlier surge in youth Juul use. []
"[This] decision puts at risk the progress our nation has made in reducing youth e-cigarette use. It conflicts with overwhelming scientific evidence and the FDA’s own repeated conclusions that flavors pose a substantial risk to young people," said Yolonda C. Richardson, President and CEO of the Campaign for Tobacco-Free Kids in a statement. []
That concern is not theoretical. In the 2024 National Youth Tobacco Survey, 1.63 million middle and high school students reported current e-cigarette use; among current youth e-cigarette users, 87.6% reported using flavored products, with fruit flavors the most commonly reported category. []
The politics around vaping are hard to miss
The FDA decision also comes in a politically charged moment. President Donald Trump had previously promised to “save” vaping. []
That political backdrop matters less in the exam room than the clinical nuance it creates. Patients may hear “FDA authorized” and interpret it as “FDA approved” or “safe.”
Physicians will likely need to clarify that the FDA’s tobacco-product standard is a population-level public health assessment, not a therapeutic endorsement for an individual patient.
The clinical middle ground: less harmful is not harmless
For adult patients who smoke traditional cigarettes, e-cigarettes may reduce exposure to some toxicants if they completely switch from smoking to vaping.
CDC guidance says e-cigarettes may have potential benefit for adults who smoke and are not pregnant if used as a complete substitute for smoked tobacco products. []
But the same CDC guidance is clear that no tobacco product is safe, e-cigarettes should not be used by youth, young adults, or pregnant patients, and adults who have never used tobacco should not start. []
The US Preventive Services Task Force also remains cautious. Its tobacco cessation recommendation concludes that evidence is insufficient to assess the balance of benefits and harms of e-cigarettes for smoking cessation in adults, including pregnant patients, and advises clinicians to direct patients toward cessation interventions with established safety and effectiveness. []
For doctors, the practical distinction is this: vaping may be a harm-reduction discussion for a patient who is currently smoking and unable or unwilling to quit with proven therapies. It is not a wellness product, a risk-free nicotine option, or a recommended starting point for nicotine-naive patients.
What doctors should watch next
The Glas authorization is likely to become a test case for whether device-level age verification can meaningfully reduce youth access to flavored nicotine products.
Truth Initiative CEO Kathy Crosby described the decision as a “key test case,” saying FDA must monitor how the products are marketed and used and act quickly if they no longer meet the agency’s public health standard. []
That monitoring will matter clinically. If flavored, age-gated products expand, physicians may see more patients asking whether FDA authorization means vaping is now medically acceptable.
Pediatricians and family physicians may also need to ask more specifically about device sharing, workarounds to age locks, and fruit-flavored products marketed under less obvious names such as “Gold” and “Sapphire.”
Related: The biggest FDA decision drops in 2026 so far: Oncology approvalsWhat to tell patients who ask about vaping
A plain-language response might sound like this:
“Some e-cigarettes are now authorized for adult sale, including a few fruit-flavored products. That does not mean they are safe or approved as quit-smoking treatments. If you don’t use nicotine, don’t start. If you smoke cigarettes, switching completely to vaping may reduce some harms compared with smoking, but the best goal is to quit nicotine entirely. We have better-studied tools to help you do that, and we can make a plan that fits where you are right now.”
For parents and adolescents, the message should be firmer:
“Flavored vapes still contain nicotine, which can be addictive and can affect the developing brain. FDA authorization for adults does not make these products safe for teens, and fruit flavors are still one of the biggest concerns for youth use.”